Skip to content
Clinical Trials – home

Milan Kvapil s.r.o.

Verifiedinfo

Czechia Michnova 1622/4, Chodov, 149 00 Prague, Czechia

  • 10 trials recruiting
  • Obesity · Overweight · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Milan Kvapil s.r.o. in Prague, Czechia specialises in clinical trials of conditions such as Obesity, Overweight, Type 2 diabetes mellitus, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular and Metabolic Disorders

The medical center is at the forefront of research in cardiovascular and metabolic disorders, with a particular focus on Severe Hypertriglyceridemia (SHTG). This condition is characterized by extremely high levels of triglycerides in the blood, which can lead to serious health complications.

  • Severe Hypertriglyceridemia (SHTG)
  • Cardiovascular Risk Management
  • Metabolic Syndrome

Through the study of olezarsen, a novel therapeutic agent administered subcutaneously, the center aims to enhance the safety and tolerability of treatments for patients with SHTG. This research contributes significantly to the development of innovative therapies that address the underlying causes of metabolic disorders, improving patient outcomes and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Michnova 1622/4, Chodov149 00 PragueCzechia
Recruiting now
10 trials
Conditions studied
11
Partner status
Verified

More sites in PragueCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

21 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 SODIUM
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Obesity

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.